Foresight to Initiate First Pilot Project for Its COVID-19 Symptom Detection Solution
Summary
NESS ZIONA, Israel--(BUSINESS WIRE)--Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision, announced today that it will begin a pilot project for its prototype COVID-19 symptom detection mass screening solution. Foresight’s solution, which is based on the Company’s extensive knowledge of thermal and visible-light cameras, artificial intelligence and advanced algorithms, is designed to rapidly and accurately detect some of the main symptoms associated with the COVID-19 virus. Based on the large number of Mehuedet clinics throughout Israel, a successful pilot project may lead to further evaluation and future commercial orders,” said Haim Siboni, CEO of Foresight. Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Foresight is targeting the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost effective platform and advanced technology.